These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5694289)

  • 1. Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.
    Day RM; Carroll FD
    Arch Ophthalmol; 1968 Mar; 79(3):279-82. PubMed ID: 5694289
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.
    Day RM; Carroll FD
    Trans Am Ophthalmol Soc; 1967; 65():41-51. PubMed ID: 5630622
    [No Abstract]   [Full Text] [Related]  

  • 3. Optic neuropathy of Graves disease, hyperthyroidism, and ocular myasthenia gravis.
    Cohen JS
    Arch Ophthalmol; 1973 Aug; 90(2):131-2. PubMed ID: 4352787
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy.
    Hiromatsu Y; Kojima K; Ishisaka N; Tanaka K; Sato M; Nonaka K; Nishimura H; Nishida H
    Thyroid; 1992; 2(4):299-305. PubMed ID: 1493371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications and results of prednisone treatment in thyroid ophthalmopathy.
    Apers RC; Oosterhuis JA; Bierlaagh JJ
    Ophthalmologica; 1976; 173(3-4):163-7. PubMed ID: 989888
    [No Abstract]   [Full Text] [Related]  

  • 6. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
    Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
    Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
    Leövey A; Bakó G; Szabó J; Kálmán K; Fórizs E
    Acta Med Hung; 1992-1993; 49(3-4):179-85. PubMed ID: 1345455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone in the treatment of exophthalmos.
    Garber MI
    Lancet; 1966 Apr; 1(7444):958-60. PubMed ID: 4160651
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
    Macchia PE; Bagattini M; Lupoli G; Vitale M; Vitale G; Fenzi G
    J Endocrinol Invest; 2001 Mar; 24(3):152-8. PubMed ID: 11314743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraocular pressure in patients with infiltrative-edematous exophthalmos in Graves' disease treated with prednisone].
    Janik J; Mroczek-Madziar D; Zgliczyński S; Górowski T; Jastrzebska H; Sek S
    Klin Oczna; 1990 Aug; 92(3-4):44-5. PubMed ID: 2263031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is treatment with corticotherapy or radiotherapy effective for involvement of ocular motility and for reduction of exophthalmos in Basedow's disease?].
    Waterschoot MP; Cordonnier M; Van Nechel C; Vanheesbeke A; Zanen A
    Bull Soc Belge Ophtalmol; 1994; 254():93-105. PubMed ID: 7493132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid eye disease.
    Clifton-Bligh P
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):233-5. PubMed ID: 2261166
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of prednisone in immunosuppressive dosage on the clinical course of eye changes and dynamics of LATS titer in the serum].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1973 May; 50(5):449-58. PubMed ID: 4740191
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D; Schrooyen M
    Horm Res; 1987; 26(1-4):184-9. PubMed ID: 3596467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome.
    Hart RH; Kendall-Taylor P; Crombie A; Perros P
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):328-36. PubMed ID: 16117697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
    Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
    Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular changes in Graves-Basedov disease].
    Nauman J
    Pol Arch Med Wewn; 1972 Nov; 49(5):463-71. PubMed ID: 4566054
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: The eye signs of Graves disease.
    Lancet; 1974 Mar; 1(7856):491. PubMed ID: 4131889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.